Claritas Pharmaceuticals, Inc. (CLAZF) Research

Operating as a clinical-stage specialty pharmaceutical entity, Claritas Pharmaceuticals, Inc. is dedicated to the creation and market introduction of medical therapies addressing significant patient needs that are currently unfulfilled. Established in 2014, the company was previously known as Kalytera Therapeutics, Inc. before rebranding to Claritas Pharmaceuticals, Inc. in April 2021. Its corporate headquarters are located in San Rafael, California.

Market snapshot

Symbol
CLAZF
Price
$0.00
Day change
0.00%
Market cap
$3.7K
P/E ratio
0.00x
52-week range
0.0001-0.0001
Sector
Healthcare
Industry
Biotechnology
Next earnings
in 2 months

Peer companies

  • Adcock Ingram Holdings Limited (AIHLF)
  • Columbia Care Inc. (CCHWF)
  • Opthea Limited (CKDXF)
  • Immune Therapeutics, Inc. (IMUN)
  • Inventiva S.A. (IVEVF)
  • PT Tempo Scan Pacific Tbk (PEXXF)
  • Supermax Corporation Berhad (SPMXF)
  • SS Innovations International, Inc. (SSII)

Open Claritas Pharmaceuticals, Inc. (CLAZF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.